[Back to Staff list]
Qualifications MB ChB (Birmingham), MRCS, LRCP (London), MRCP (UK), FRCP (London), FRACP. Career Ralph Edwards trained in both general internal medicine and clinical pharmacology. He has been a practicing specialist physician and also taught at undergraduate and graduate levels in both areas for 17 years. He worked in clinical toxicology in the fields of drug abuse, acute and chronic poisoning, toxicity from industrial chemicals as well as adverse drug reactions. 1967-1975 he held various posts at the University of Sheffield Medical School and United Sheffield Hospitals (UK) then from 1975-1978 at the University of Leicester Medical School and Hospitals (UK). From 1978-1981 he was Professor of Medicine at the University of Zimbabwe, Consultant physician, a Founder member of ISLAND hospice team, Zimbabwe and Consultant and Board member, Drug Abuse Support Team, Harare. Between 1981 and 1990 Ralph Edwards was Director of the National Toxicology Group and Associate Professor in Clinical Pharmacology, Otago University and Medical Research Council, Consultant Physician, Dunedin Hospital, Chairman, Dunedin Hospital Therapeutics Committee, Medical Assessor for Adverse Drug Reactions, Ministry of Health New Zealand and a member of various advisory committees in New Zealand. From 1985 to 1990 he was Chairperson of the Advisory Group, WHO Collaborating Centre for International Drug Monitoring, Uppsala, Sweden. From 1990 to 2009 Ralph was Director of the Uppsala Monitoring Centre.Other positions External examiner in clinical pharmacology, University of Zimbabwe, Cape Town and Witswatersrand Universities, South Africa (variously, from 1992 onwards) and in Clinical Toxicology, University of Cardiff, UK (1999-2009). President, International Society of Pharmacovigilance (2000-2004). Member, WHO Expert Advisory Group on Essential Drugs (2000-2002), Member, WHO Expert Advisory Group on Narcotic and Psychotropic Drugs (2002) Research and publications In the last ten years his research has been in the identification and confirmation of ADRs using post-marketing cohort studies and longitudinal health care records; international analysis of ADR and toxicology case report rates, drug use and demography. Recent focus has been on drug benefit-risk analysis and the use of data mining/knowledge detection as an aid to the analysis of large amounts of case data. A full list of publications is available on request. He has also been an initiator in good communications practice on drug benefit and risk.
Currently Working on medical and legal aspects of causality evaluation, as well as issues of risk and benefit evaluation and data mining approaches to support signal detection and evaluation.
Outside his work at the UMC, his hobbies include sailing, skiing, nature conservation, and the preservation of old cars and houses.
E-mails email@example.com firstname.lastname@example.org
Ralph Edwards page last updated 26 January 2011
[Top of page]
Uppsala Monitoring Centre · Tel: +46 18 65 60 60 · Fax: +46 18 65 60 88